The Scientific Research Team at MLL Münchner Leukämielabor GmbH is composed of biologists, molecular geneticists, and scientists who collaborate to advance hematological research and diagnostics. Utilizing cutting-edge technologies, such as artificial intelligence, and a range of methodologies including cytomorphology, chromosome analysis, and various molecular genetic techniques, the team aims to enhance the understanding and characterization of leukemias and lymphomas. Their commitment ensures the development of innovative diagnostic solutions to improve patient outcomes on a global scale.